{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:07:40Z","timestamp":1781222860103,"version":"3.54.1"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010658","name":"St Paul's Foundation of Vancouver","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010658","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000245","name":"Michael Smith Health Research BC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019265","name":"Carraresi Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence Reports"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.dadr.2026.100439","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T23:33:17Z","timestamp":1776468797000},"page":"100439","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Use of benzodiazepines and medications for opioid use disorder for withdrawal management in a hospital-based setting for individuals exposed to benzodiazepine-contaminated fentanyl: A case series"],"prefix":"10.1016","volume":"19","author":[{"given":"Alexander","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seonaid","family":"Nolan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paxton","family":"Bach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9e M.","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis J.","family":"De Wolfe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piper","family":"Dickhout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhea","family":"Beauchesne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheyenne","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Addie","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bohdan","family":"Nosyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany B.","family":"Dennis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dadr.2026.100439_bib1","unstructured":"British Columbia Centre on Substance Use, BC Ministry of Health, BC Ministry of Mental Health and Addictions, 2023. A guideline for the clinical management of opioid use disorder. \u3008https:\/\/www.bccsu.ca\/opioid-use-disorder\/\u3009 (accessed 13 March 2024)."},{"key":"10.1016\/j.dadr.2026.100439_bib2","unstructured":"British Columbia Centre on Substance Use, BC Ministry of Health, Ministry of Mental Health and Addictions, 2022. Risk mitigation in the context of dual health emergencies\u2014interim clinical guidance: update. \u3008https:\/\/www.bccsu.ca\/COVID-19\u3009 (accessed 13 March 2024)."},{"key":"10.1016\/j.dadr.2026.100439_bib3","unstructured":"British Columbia Centre on Substance Use, 2024. Fentanyl patch \u2013 prescribed safer supply protocols. \u3008https:\/\/www.bccsu.ca\/wp-content\/uploads\/2024\/04\/Prescribed-Safer-Supply-Protocols-Fentanyl-Patch.pdf\u3009 (accessed 13 March 2024)."},{"key":"10.1016\/j.dadr.2026.100439_bib4","series-title":"META","article-title":"Methadone treatment for people who use fentanyl: Recommendations","author":"Bromley","year":"2021"},{"issue":"9","key":"10.1016\/j.dadr.2026.100439_bib5","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-090608","article-title":"Road to recovery: protocol for a mixed-methods prospective cohort study evaluating the impact of a new model of substance use care in a Canadian setting","volume":"14","author":"Dennis","year":"2024","journal-title":"BMJ Open"},{"key":"10.1016\/j.dadr.2026.100439_bib6","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jclinepi.2017.04.026","article-title":"CARE guidelines for case reports: explanation and elaboration","volume":"89","author":"Gagnier","year":"2017","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.dadr.2026.100439_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2025.104751","article-title":"Not just fentanyl: understanding the complexities of the unregulated opioid supply through results from a drug checking service in British Columbia, Canada","volume":"138","author":"Gonzalez-Nieto","year":"2025","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.dadr.2026.100439_bib8","series-title":"More than 2,500 lives lost to toxic drugs in 2023","author":"Government of British Columbia","year":"2024"},{"key":"10.1016\/j.dadr.2026.100439_bib9","unstructured":"Health Canada, 2024. Opioid- and stimulant-related harms in Canada. \u3008https:\/\/health-infobase.canada.ca\/substance-related-harms\/opioids-stimulants\/\u3009 (accessed 13 March 2024)."},{"issue":"4","key":"10.1016\/j.dadr.2026.100439_bib10","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/CXA.0000000000000221","article-title":"Unanticipated benzodiazepine withdrawal in the context of an adulterated unregulated opioid supply in Vancouver, BC: a case series","volume":"15","author":"Laing","year":"2024","journal-title":"Can. J. Addict."},{"key":"10.1016\/j.dadr.2026.100439_bib11","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1300\/J069v26n03_08","article-title":"Factors associated with pre-treatment and treatment dropouts among clients admitted to medical withdrawal management","volume":"26","author":"Li","year":"2007","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.dadr.2026.100439_bib12","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/dar.13311","article-title":"Predictors of and reasons for early discharge from inpatient withdrawal management settings: a scoping review","volume":"41","author":"Ling","year":"2022","journal-title":"Drug Alcohol Rev."},{"issue":"2","key":"10.1016\/j.dadr.2026.100439_bib13","doi-asserted-by":"crossref","first-page":"204","DOI":"10.31389\/jied.122","article-title":"Potency-enhancing synthetics in the drug overdose epidemic: Xylazine (\"tranq\"), fentanyl, methamphetamine, and the displacement of heroin in Philadelphia and Tijuana","volume":"4","author":"Montero","year":"2022","journal-title":"J. Illicit Econ. Dev."},{"key":"10.1016\/j.dadr.2026.100439_bib14","unstructured":"National Center for Health Statistics, 2022. Drug overdose mortality by state. \u3008https:\/\/www.cdc.gov\/nchs\/pressroom\/sosmap\/drug_poisoning_mortality\/drug_poisoning.htm\u3009 (accessed 23 September 2024)."},{"key":"10.1016\/j.dadr.2026.100439_bib15","unstructured":"National Institute on Drug Abuse, 2021. National drug-involved overdose deaths by gender, 1999\u20132021. \u3008https:\/\/nida.nih.gov\/research-topics\/trends-statistics\/overdose-death-rates\u3009 (accessed 13 March 2024)."},{"key":"10.1016\/j.dadr.2026.100439_bib16","unstructured":"National Institute on Drug Abuse, 2025. Benzodiazepines and opioids. \u3008https:\/\/nida.nih.gov\/research-topics\/opioids\/benzodiazepines-opioids\u3009 (accessed 20 July 2025)."},{"key":"10.1016\/j.dadr.2026.100439_bib17","first-page":"CD003971","article-title":"Methadone for cancer pain","volume":"2","author":"Nicholson","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.dadr.2026.100439_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2022.103933","article-title":"The increase in benzodiazepine-laced drugs and related risks in Canada: the urgent need for effective and sustainable solutions","volume":"111","author":"Russell","year":"2023","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.dadr.2026.100439_bib19","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1080\/09595230701750650","article-title":"Residential detoxification: essential for marginalised, severely alcohol- and drug-dependent individuals","volume":"27","author":"Silins","year":"2008","journal-title":"Drug Alcohol Rev."},{"issue":"6","key":"10.1016\/j.dadr.2026.100439_bib20","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/ADM.0000000000001216","article-title":"Self-reported xylazine experiences: a mixed-methods study of Reddit subscribers","volume":"17","author":"Spadaro","year":"2023","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.dadr.2026.100439_bib21","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/j.1360-0443.1989.tb00737.x","article-title":"Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar)","volume":"84","author":"Sullivan","year":"1989","journal-title":"Br. J. Addict."},{"issue":"8","key":"10.1016\/j.dadr.2026.100439_bib22","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1177\/2047487315602861","article-title":"Statin tolerability: in defence of placebo-controlled trials","volume":"23","author":"Tobert","year":"2016","journal-title":"Eur. J. Prev. Cardiol."}],"container-title":["Drug and Alcohol Dependence Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772724626000326?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772724626000326?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T23:46:32Z","timestamp":1781221592000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772724626000326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":22,"alternative-id":["S2772724626000326"],"URL":"https:\/\/doi.org\/10.1016\/j.dadr.2026.100439","relation":{},"ISSN":["2772-7246"],"issn-type":[{"value":"2772-7246","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of benzodiazepines and medications for opioid use disorder for withdrawal management in a hospital-based setting for individuals exposed to benzodiazepine-contaminated fentanyl: A case series","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dadr.2026.100439","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100439"}}